切换至 "中华医学电子期刊资源库"
高级检索
中华肥胖与代谢病电子杂志

中华肥胖与代谢病电子杂志 ›› 2023, Vol. 09 ›› Issue (04) : 237 -245. doi: 10.3877/cma.j.issn.2095-9605.2023.04.003

论著

基于CiteSpace的近20年减重对心血管系统影响的可视化分析
彭荣刚1, 杨芳2, 刘倩1, 杨亚娟2, 赵庆2,†()   
  1. 1. 214026　无锡，江南大学附属医院心内科
    2. 214023　无锡，南京医科大学附属无锡人民医院CCU
  • 收稿日期:2023-11-22 出版日期:2023-11-30
  • 通信作者: 赵庆
  • 基金资助:
    国家自然科学基金青年项目(82200357); 无锡市科技局项目(Y20212023)

CiteSpace-based visual analysis of the impact of weight loss on the cardiovascular system in the past 20 years

Ronggang Peng1, Fang Yang2, Qian Liu1, Yajuan Yang1, Qing Zhao2,†()   

  1. 1. Cardiology Department, Affiliated Hospital of Jiangnan University, Wuxi 214026, China
    2. CCU, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China
  • Received:2023-11-22 Published:2023-11-30
  • Corresponding author: Qing Zhao
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

彭荣刚, 杨芳, 刘倩, 杨亚娟, 赵庆. 基于CiteSpace的近20年减重对心血管系统影响的可视化分析[J/OL]. 中华肥胖与代谢病电子杂志, 2023, 09(04): 237-245.

Ronggang Peng, Fang Yang, Qian Liu, Yajuan Yang, Qing Zhao. CiteSpace-based visual analysis of the impact of weight loss on the cardiovascular system in the past 20 years[J/OL]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2023, 09(04): 237-245.

目的

检索2003—2022年减重在心血管领域的相关文献，探究该领域的国际研究热点与发展趋势。

方法

以Web of Science （WOS）为来源检索相关文献，分析年度发文量。运用文献计量学工具CiteSpace对国家、机构、作者、关键词进行可视化分析。

结果

共获得3 946篇文献，来自106个国家、514家研究机构的799位作者在该领域发表研究。发文量呈上升趋势，美国发文量最多，中国发文量位居第六。哈佛大学是发文量最多的研究机构，各研究机构间存在一定的合作。来自美国梅奥医学中心的Lavie CJ教授在该研究领域的产出最多，研究作者以团队为单位合作密切。北京协和医学院是中国发文量最多的研究机构，但与国际相比仍存在较大差距。关键词分析结果显示，减重在心血管领域的研究主要关注运动和减重手术对心衰、冠心病、房颤等心血管疾病的效果及作用机制。

结论

减重在心血管领域的研究受到越来越多关注，且减重对心血管疾病的防治效果在大量研究中得以证实，但是关于"肥胖悖论"的争议仍需进一步探讨减重方式与心血管获益的相关实践与机制。

关键词: 减重, 心血管系统, 可视化分析, CiteSpace
Objective

To retrieve relevant literature on weight reduction in the cardiovascular field from 2003 to 2022 and explore the international research hotspots and development trends in this field.

Methods

Relevant literature was retrieved from the Web of Science (WOS), and the annual publication volume was analyzed. Visual analysis of countries, institutions, authors, and keywords was conducted using the CiteSpace tool.

Results

3946 articles were obtained from 799 authors affiliated with 514 research institutions in 106 countries. The publication volume showed an increasing trend, with the United States having the highest publication volume and China ranking sixth. Harvard University had the highest publication volume among research institutions, and there was some collaboration between various institutions. Professor Lavie Carl J from the Mayo Clinic in the United States had the highest output in this research field. There was close collaboration among research authors as a team. The Peking Union Medical College had the highest publication volume among Chinese research institutions but still lagged internationally. Keyword analysis indicated that research on weight reduction in the cardiovascular field primarily focused on the effects and mechanisms of exercise and bariatric surgery on cardiovascular diseases such as heart failure, coronary heart disease, and atrial fibrillation.

Conclusions

Research on weight reduction in the cardiovascular field is receiving increasing attention, and the preventive and therapeutic effects of weight reduction on cardiovascular diseases have been confirmed in numerous studies. However, the controversy surrounding the "obesity paradox" requires further exploration of the relevant practices and mechanisms of weight reduction and cardiovascular benefits.

Key words: Weight reduction, Cardiovascular system, Visual analysis, CiteSpace
图1 减重对心血管系统影响相关研究的年度发文量注：*表示相应年份发表的重要文献，对该研究领域有重要引领作用[11,12,13,14]
图2 减重对心血管系统影响相关研究的国家共现图谱注：图中节点代表国家，节点越大表示发文量越多；节点间连线表示国家间合作，连线粗细表示合作强弱；颜色代表文献发表年份，左下角颜色从下到上为2003—2022年
表1 减重对心血管系统影响相关研究的发文量排名前十国家
排名 国家 发文量 中心性
1 美国 1740 0.11
2 英国 385 0.04
3 意大利 358 0.00
4 德国 351 0.04
5 加拿大 303 0.12
6 中国 294 0.00
7 日本 213 0.00
8 澳大利亚 206 0.04
9 荷兰 159 0.11
10 法国 147 0.11
图3 减重对心血管系统影响相关研究的研究机构共现图谱注：图中节点代表机构，节点越大表示发文量越多；节点间连线表示机构间合作，连线粗细表示合作强弱；颜色代表文献发表年份，左下角颜色从下到上为2003—2022年
表2 减重对心血管系统影响相关研究的发文量排名前十研究机构
排名 研究机构 发文量 中心性
1 哈佛大学 266 0.01
2 布列根和妇女医院 154 0.15
3 加州大学 148 0.02
4 哈佛医学院 147 0.00
5 杜克大学 131 0.04
6 梅奥医学中心 112 0.00
7 伦敦大学 105 0.04
8 美国退伍军人事务部 97 0.05
9 德克萨斯大学 96 0.04
10 退役军人医疗管理局 92 0.06
图4 减重对心血管系统影响相关研究的作者合作共现图谱注：图中节点代表作者，节点越大表示发文量越多；节点间连线表示作者间合作，连线粗细表示合作强弱；颜色代表文献发表年份，左下角颜色从下到上为2003—2022年
图5 减重对心血管系统影响相关研究的关键词共现分析注：图中节点代表关键词，节点越大表示出现频次越高；节点间连线表示关键词共现，连线粗细表示关联强度；颜色代表文献发表年份，左下角颜色从下到上为2003—2022年
图6 减重对心血管系统影响相关研究的关键词聚类分析注：图中每个色块代表一组紧密相关的关键词，聚类标签是聚类内部关键词的代表
表3 减重对心血管系统影响相关研究的关键词聚类标签表
聚类标签 轮廓值 关键词
减重 0.92 减重，舒张功能，T波形态，QRS间期，心衰
心衰 0.95 心衰，心肌重构，共焦显微镜，动脉硬化，心室重塑
房颤 0.94 心房颤动，心包脂肪，肿瘤恶病质，心功能，桥接
运动锻炼 0.95 运动锻炼，心血管疾病，心肺功能，肥胖悖论，内皮功能
先心病 0.86 先心病，心脏手术，重症监护，口服抗凝，定性分析
心血管疾病 0.95 心衰，房颤，心血管疾病，减重术，冠心病
BMI 0.98 身体质量指数，糖尿病，心血管疾病，危险因素，腰围
回顾性研究 0.91 心衰，回顾性研究，酰化肽，信息技术，心外膜脂肪
减重术 0.95 减重术，心衰,心血管疾病，房颤，心肌梗死
冠心病 0.95 心血管疾病，冠心病，减重术，心衰，静脉栓塞
减重 0.96 心衰，减重，质保协议，风险评估，充血性心衰
静脉栓塞 0.96 房颤，静脉栓塞，直接口服抗凝剂，低分子肝素，心脏再同步化治疗
血容量 0.90 心衰，血容量，氯化钠，钠钾氯共转运蛋白，30天再入院
系统评价 0.99 心衰，系统评价，序列分析，GLP-1受体激动剂，动态血压监测
动脉硬化 0.96 动脉硬化，血压，脉搏波传导速度，胰岛素抵抗，儿童肥胖
蛋白质百分比 0.96 减重，蛋白质百分比，右室功能不全，栓塞保护装置，主动脉瓣置换
心肌梗死 1 心肌梗死，心功能，心脏重塑，ACEI，β受体阻滞剂
图7 减重对心血管系统影响相关研究的关键词突现图谱注：Year表示统计起始年，Strength代表关键词突现强度，Begin代表该词最早出现时间，End代表该词最晚出现时间，红色线条代表关键词突现的时间区段
[1]
Chen K, Shen Z, Gu W, et al. Prevalence of obesity and associated complications in China: A cross-sectional, real-world study in 15.8 million adults [J]. Diabetes, obesity & metabolism, 2023, 25(11): 3390-3399.
[2]
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2022概要[J]. 中国循环杂志, 2023, 38(06): 583-612.
[3]
Larsson SC, Bäck M, Rees JMB, et al. Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study [J]. Eur Heart J, 2020, 41(2): 221-226.
[4]
Fekri N, Khaloo P, Ramezankhani A, et al. Association of body mass index with life expectancy with and without cardiovascular disease [J]. International journal of obesity (2005), 2020, 44(1): 195-203.
[5]
Zhao Y, Yu B Y, Liu Y, et al. Weight reduction and cardiovascular benefits: Protocol for a systematic review and meta-analysis [J]. Medicine, 2018, 97(50): e13246.
[6]
中华医学会心血管病学分会，中国康复医学会心脏预防与康复专业委员会，中国老年学和老年医学会心脏专业委员会等. 中国心血管病一级预防指南 [J]. 中华心血管病杂志, 2020, 48(12): 1000-1038.
[7]
Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice [J]. Eur Heart J, 2021, 42(34): 3227-3337.
[8]
Simati S, Kokkinos A, Dalamaga M, et al. Obesity Paradox: Fact or Fiction? [J]. Curr Obes Rep, 2023, 12(2): 75-85.
[9]
Chen C, Chen Y, Hou J, et al. CiteSpace Ⅱ: Detecting and Visualizing Emerging Trends and Transient Patterns in Scientific Literature [J]. Journal of the China Society for Scientific and Technical Information, 2009, 28(3): 401-421.
[10]
姚雪, 徐川平, 李杰, 等. 基于普赖斯定律和二八定律及在线投稿系统构建某科技期刊核心作者用户库 [J]. 编辑学报, 2017, 29(1): 64-66.
[11]
Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism [J]. Circulation, 2006, 113(6): 898-918.
[12]
Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society [J]. Circulation, 2014, 129(25 Suppl 2): S102-138.
[13]
Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [J]. Circulation, 2019, 140(11): e563-e595.
[14]
Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association [J]. Circulation, 2021, 143(21): e984-e1010.
[15]
赵宁, 王宇, 王清波, 等. 过去10年我国减重代谢手术的研究进展 [J/CD ]. 中华肥胖与代谢病电子杂志, 2019, 5(3): 123-127.
[16]
Roth GA, Johnson C, Abajobir A, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 [J]. J Am Coll Cardiol, 2017, 70(1): 1-25.
[17]
Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss [J]. J Am Coll Cardiol, 2009, 53(21): 1925-1932.
[18]
Lavie CJ, Ross R, Neeland IJ. Physical activity and fitness vs adiposity and weight loss for the prevention of cardiovascular disease and cancer mortality [J]. Int J Obes (Lond), 2022, 46(12): 2065-2067.
[19]
Doehner W, Gerstein HC, Ried J, et al. Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial [J]. Eur Heart J, 2020, 41(28): 2668-2677.
[20]
Semlitsch T, Stigler FL, Jeitler K, et al. Management of overweight and obesity in primary care-A systematic overview of international evidence-based guidelines [J]. Obes Rev, 2019, 20(9): 1218-1230.
[21]
Bray G A, Frühbeck G, Ryan D H, et al. Management of obesity [J]. Lancet, 2016, 387(10031): 1947-1956.
[22]
Celik O, Yildiz BO. Obesity and physical exercise [J]. Minerva Endocrinol (Torino), 2021, 46(2): 131-144.
[23]
Oppert JM, Bellicha A, van Baak MA, et al. Exercise training in the management of overweight and obesity in adults: Synthesis of the evidence and recommendations from the European Association for the Study of Obesity Physical Activity Working Group [J]. Obes Rev, 2021, 22 Suppl 4(Suppl 4): e13273.
[24]
Shi Q, Wang Y, Hao Q, et al. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials [J]. Lancet, 2022, 399(10321): 259-269.
[25]
Neeland IJ, McGuire DK, Sattar N. Cardiovascular Outcomes Trials for Weight Loss Interventions: Another Tool for Cardiovascular Prevention? [J]. Circulation, 2021, 144(17): 1359-1361.
[26]
Jensen SBK, Janus C, Lundgren JR, et al. Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment [J]. Nat Commun, 2022, 13(1): 4770.
[27]
van Rijswijk AS, van Olst N, Schats W, et al. What Is Weight Loss After Bariatric Surgery Expressed in Percentage Total Weight Loss (%TWL)? A Systematic Review [J]. Obes Surg, 2021, 31(8): 3833-3847.
[28]
O'Brien PE, Hindle A, Brennan L, et al. Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding [J]. Obes Surg, 2019, 29(1): 3-14.
[29]
Chi M, Nie Y, Su Y, et al. Effects of weight loss in heart failure patients with overweight and obesity: a systematic review and meta-analysis [J]. Eur J Prev Cardiol, 2023.
[30]
Sundström J, Bruze G, Ottosson J, et al. Weight Loss and Heart Failure: A Nationwide Study of Gastric Bypass Surgery Versus Intensive Lifestyle Treatment[J]. Circulation, 2017, 135(17): 1577-1585.
[31]
Chandrakumar H, Khatun N, Gupta T, et al. The Effects of Bariatric Surgery on Cardiovascular Outcomes and Cardiovascular Mortality: A Systematic Review and Meta-Analysis [J]. Cureus, 2023, 15(2): e34723.
[32]
Fantin F, Giani A, Zoico E, et al. Weight Loss and Hypertension in Obese Subjects [J]. Nutrients, 2019, 11(7): 1667.
[33]
王滢莹, 秦俭, 程丽芳. 肥胖悖论与心血管疾病 [J]. 心血管病学进展, 2022, 43(1): 52-55.
[34]
Tutor AW, Lavie CJ, Kachur S, et al. Updates on obesity and the obesity paradox in cardiovascular diseases [J]. Prog Cardiovasc Dis, 2023, 7(8): 2-10.
[35]
Alebna P L, Mehta A, Yehya A, et al. Update on obesity, the obesity paradox, and obesity management in heart failure [J]. Prog Cardiovasc Dis, 2024, 9: S0033-0620(24)00003-3.
[36]
Bostrom JA, Mottel B, Heffron SP. Medical and Surgical Obesity Treatments and Atherosclerosis: Mechanisms beyond Typical Risk Factors [J]. Curr Atheroscler Rep, 2021, 23(10): 60.
[37]
彭荣刚, 张毅, 宛荣豪, 等. 肥胖症患者减重术后心脏结构功能变化及其机制的研究进展 [J]. 中国心血管杂志, 2020, 25(6): 588-590.
[38]
Lopez-Jimenez F, Almahmeed W, Bays H, et al. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation [J]. Eur J Prev Cardiol, 2022, 29(17): 2218-37.
[39]
Ahammed MR, Ananya FN. Impact of Weight Loss on Atrial Fibrillation [J]. Cureus, 2023, 15(9): e46232.
[40]
Blüher M, Aras M, Aronne LJ, et al. New insights into the treatment of obesity [J]. Diabetes Obes Metab, 2023, 25(8): 2058-2072.
[41]
Rieth AJ, Hamm CW, Wanner C, et al. [Heart failure protection by SGLT2 inhibitors in patients with type 2 diabetes mellitus: evidence and possible mechanisms: A systematic review [J]. Herz, 2021, 46(Suppl 2): 151-158.
[1] 肖琦钦, 赵文丽, 任明君, 林丽丽, 刘尧, 苏展. 我国颞下颌关节专业学位论文的发展及演进分析[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 250-256.
[2] 许革新, 何琦, 毛智军, 普彦淞, 杨淦傑, 王建华. 我国胃肿瘤外科治疗现状及发展趋势—基于CiteSpace的可视化分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 350-356.
[3] 杨波, 胡旭, 何金艳, 谢铭. 腹腔镜袖状胃切除术管胃固定研究现状[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 452-455.
[4] 张燕, 许丁伟, 胡满琴, 李新成, 李翱, 黄洁. 胆囊癌免疫治疗的知识图谱可视化分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 319-327.
[5] 张耕毓, 唐冲, 张昆, 张辉, 张清华, 刘家帮. 股骨头坏死髓芯减压术的文献计量学分析及单中心病例报道[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 771-780.
[6] 中国医师协会外科医师分会肥胖代谢病综合管理与护理专家工作组, 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国肥胖代谢外科研究协作组. 肥胖代谢外科医学科普中国专家共识（2024 版）[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 227-234.
[7] 李兆, 李兆鹏, 宋逸, 郭栋, 陈栋, 李宇. 腹腔镜袖状胃切除术后残胃容积的测量方案及评价[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 242-247.
[8] 王鹏鹏, 周涵苓, 孟化, 刘宝胤. 减重手术后皮肤松弛的塑形手术现状与展望[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 248-254.
[9] 张鑫, 刘志芬, 郭云童. 肥胖与抑郁症相关性的研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 255-260.
[10] 孙伟, 徐东升. 减重与代谢外科肝脏悬吊方式研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 261-268.
[11] 孙琴, 梁钿苑, 张源, 任亦星. 代谢异常型肥胖患者对肥胖和减重手术的认知调查研究[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 295-299.
[12] 郭明杰, 周春起, 余佳慧, 李世红, 朱红梅, 刘雁军, 杨华武. 肥胖与胃食管反流病的关系及减重术后反流治疗研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 184-192.
[13] 王思奇, 张念荣, 周彪, 刘宝胤, 孟化. 肥胖与胆囊疾病研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 177-183.
[14] 张怡然, 刘宝胤, 聂云韬, 孟化. 减重手术对甲状腺功能影响的研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 170-176.
[15] 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国医师协会外科医师分会胃食管反流疾病诊疗外科专家工作组, 日本肥胖治疗学会, 韩国减重与代谢外科学会. 袖状胃切除术患者胃食管反流病诊治专家共识（2024版）[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 145-162.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号

AI
小
编
AI小编
你好！我是《中华医学电子期刊资源库》AI小编，有什么可以帮您的吗？